Zhou YT, Yu LS, Zeng S, Huang YW, Xu HM, & Zhou Q. (2013). Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: Factors determining interaction strength and relevant clinical risk management. Dove Medical Press.
Chicago Style (17th ed.) CitationZhou YT, Yu LS, Zeng S, Huang YW, Xu HM, and Zhou Q. Pharmacokinetic Drug–drug Interactions Between 1,4-dihydropyridine Calcium Channel Blockers and Statins: Factors Determining Interaction Strength and Relevant Clinical Risk Management. Dove Medical Press, 2013.
MLA (9th ed.) CitationZhou YT, et al. Pharmacokinetic Drug–drug Interactions Between 1,4-dihydropyridine Calcium Channel Blockers and Statins: Factors Determining Interaction Strength and Relevant Clinical Risk Management. Dove Medical Press, 2013.